From external to implantable insulin pump, can we close the loop?;De la pompe externe à la pompe implantable, la fermeture de la boucle est-elle possible?

Diabetes and Metabolism

Volumn 28, Issue 4 II, 2002, Pages

  Renard, E ^a   Costalat, G ^a   Bringer, J ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

Artificial beta cell; Closed loop; Glucose sensor; Insulin; Insulin pump

Indexed keywords

BIOMATERIAL; INSULIN;

ALGORITHM; BIOSENSOR; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; CONFERENCE PAPER; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; DRUG IMPLANTATION; HUMAN; INSULIN PUMP; INSULIN TREATMENT;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN; INSULIN INFUSION SYSTEMS;

EID: 0013011237     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Jaremko J, Rorstad O. Advances toward the implantable artificial pancreas for treatment of diabetes. Diabetes Care, 1998, 21, 444-450.
2. Mecklenburg RS, Benson JW Jr, Becker NM, et al. Clinical use of the insulin infusion pump in 100 patients with type 1 diabetes. N Engl J Med, 1982, 307, 513-518.
3. Daubresse JC, Henrivaux P, Bailly A, Lemy C, Duchateau A. Long-term management of insulin-treated diabetic patients with continuous subcutaneous insulin infusion. Diabete Metab, 1983, 9, 45-52.
4. Helve E, Koivisto VA, Lehtonen A, Pelkonen R, Huttunen JK, Nikkila EA. Cross-over comparison of continuous insulin infusion and conventional injection treatment of type 1 diabetes. Acta Med Scand, 1987, 221, 385-393.
5. Haakens K, Hanssen KF, Dahl-Jorgensen K, Vaaler S, Aagenaes O, Mosand R. Continuous subcutaneous insulin infusion (CSII), multiple injections (MI) and conventional insulin therapy (CT) in self-selecting insulin-dependent diabetic patients. A comparison of metabolic control, acute complications and patient preferences. J Int Med, 1990, 228, 457-464.
6. Selam JL, Charles MA. Devices for insulin administration. Diabetes Care, 1990, 13, 955-979.
7. Houtzagers CMGJ. Subcutaneous insulin delivery: present status. Diabetic Med, 1989, 6, 754-761.
8. Mecklenburg RS, Benson EA, Benson JW Jr, et al. Acute complications associated with insulin infusion pump therapy. Report of experience with 181 patients. JAMA, 1984, 252, 3265-3269.
9. The Diabetes Control and Complications Trial Research Group. Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes Care, 1995, 18, 361-376.
10. Zinman B, Tildesley H, Chiasson JL, Tsui E, Strack T. Insulin lispro in CSII: results of double-blind crossover study. Diabetes, 1997, 46, 440-443.
11. 1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps. Diabetes Care, 1998, 21, 977-982.
12. Schade DS, Eaton RP, Davis T, et al. The kinetics of peritoneal insulin absorption. Metabolism, 1981, 30, 149-155.
13. Nelson JA, Stephen R, Landau ST, Wilson DE, Tyler FH. Intraperitoneal insulin administration produces a positive portal-systemic blood insulin gradient in unanesthetized, unrestrained swine. Metabolism, 1982, 31, 969-972.
14. Hanaire-Broutin H, Broussolle C, Jeandidier N, et al. Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM: A multicenter study. Diabetes Care, 1995, 18, 388-392.
15. Broussolle C, Jeandidier N, Hanaire-Broutin H, the EVADIAC Study Group. French multicenter experience of implantable insulin pumps. Lancet, 1994, 343, 514-515.
16. 1c between implantable insulin pumps using U400 HOE 21 Ph insulin and external pumps using lispro in type 1 diabetic patients: a pilot study. Diabetes Metab, 2002, 28, 133-137.
17. Renard E, Souche C, Jacques-Apostol D, et al. Improved stability of insulin delivery from implanted pumps using a new preparation process for infused insulin. Diabetes Care, 1999, 22, 1371-1372.
18. Gin H, Melki V, Guerci B, Catargi B, EVADIAC Study Group. Clinical evaluation of a newly designed compliant side port catheter for an insulin implantable pump. Diabetes Care, 2001, 24, 175.
19. Renard E, Bouteleau S, Jacques-Apostol D, et al. Insulin underdelivery from implanted pumps using peritoneal route: determinant role of insulin-pump compatibility. Diabetes Care, 1996, 19, 812-817.
20. Lassmann-Vague V, Guerci B, Hanaire-Broutin H, et al on behalf of the EVADIAC Group. Use of implantable insulin pumps: The EVADIAC position. Diabetes Metab, 1997, 23, 234-240.
21. Renard E, Lauton D, Bonifacj C, et al. Experience with intraperitoneal insulin infusion from implantable programmable systems in type 1 (insulin-dependent) diabetes mellitus previously treated by external pumps. Diabetes Metab, 1993, 19, 364-371.
22. Gough D, Armour JC. Development of the implantable glucose sensor: what are the prospects and why is it taking so long? Diabetes, 1995, 44, 1005-1009.
23. Gough DA, Armour JC, Baker DA. Advances and prospects in glucose assay technology. Diabetologia, 1997, 40 (Suppl 2), S102-S107.
24. Johnson KW, Mastrototaro JJ, Howey DC et al. In vivo evaluation of an electroenzymatic glucose sensor implanted in subcutaneous tissue. Biosens Bioelectron, 1992, 7, 709-714.
25. Kerner W, Kiwit M, Linke B, Keck FS, Zier H, Pfeiffer EF. The function of a hydrogen peroxide-detecting electroenzymatic glucose electrode is markedly impaired in human subcutaneous tissue and plasma. Biosens Bioelectron, 1993, 8, 473-482.
26. Tse PHS, Gough DA. Time-dependent inactivation of immobilized glucose oxidase and catalase. Biotech Bioengin, 1986, 29, 705-713.
27. Armour JC, Lucisano JY, McKean BD, Gough DA. Application of chronic intravascular blood glucose sensor in dogs. Diabetes, 1990, 39, 1519-1526.
28. Rebrin K, Steil GM, Van Antwerp WP, Mastrototaro JJ. Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring. Am J Physiol, 1999, 277 (Endocrinol Metab 40), E561-E571.
29. Shah R, Miller M, Zhang Y et al. Glucose sensor control of an implantable insulin pump (Abstract). Diabetes, 2000, 49 (Suppl 1), A125-A126, 509-P.
30. Renard E, Costalat G, Moran B et al. First combined implantations of a long-term IV glucose sensor and an intra-peritoneal insulin pump in diabetic patients (Abstract). Diabetes, 2001, 50 (Suppl 2), A3, 12-OR.
31. Renard E, Jovanovic L, Costalat G et al. First implantations of a long term glucose sensor connected to insulin pumps in diabetic humans (Abstract). Diabetologia, 2001, 44 (Suppl 1), A45, 169.
32. Renard E, Shah R, Miller M et al. Pompe à insuline implantée avec détecteur de glucose IV à long terme exactitude de la mesure glycémique et premiers essais de perfusion d'insuline "en boucle fermée" (Abstract). Diabetes Metab, 2002, 28, 1S31, O62.